Open Access

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
37 presentations
7 followers

4 more presentations in this session

Challenges in atherosclerotic cardiovascular disease reduction and triglyceride-related risk

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Perspectives on the results of recent clinical outcome trials with icosapent ethyl

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Integrating icosapent ethyl in cardiovascular risk reduction strategies: practical guidance

Speaker: Doctor P. Taub (La Jolla, US)

Thumbnail

Discussion

Speaker: Professor P. Libby (Boston, US) Professor E. Stroes (Amsterdam, NL) Professor P. Steg (Paris, FR) Doctor P. Taub (La Jolla, US)

Thumbnail

Access the full session

Improving the management of patients with atherosclerotic cardiovascular disease: the evolving role of icosapent ethyl

Speakers: Professor P. Libby, Professor E. Stroes, Professor P. Steg, Doctor P. Taub, Professor P. Libby...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations